An agile pharma startup with a promising molecule in Phase III clinical trials desired to effectively build brand awareness and educate three distinct audiences on the effects of migraines and the treatment options that could potentially mitigate complications for patients with cardiovascular concerns.
An agile pharma startup with a promising molecule in Phase III clinical trials desired to effectively build brand awareness and educate three distinct audiences on the effects of migraines and the treatment options that could potentially mitigate complications for patients with cardiovascular concerns.
An agile pharma startup with a promising molecule in Phase III clinical trials desired to effectively build brand awareness and educate three distinct audiences on the effects of migraines and the treatment options that could potentially mitigate complications for patients with cardiovascular concerns.
An agile pharma startup with a promising molecule in Phase III clinical trials desired to effectively build brand awareness and educate three distinct audiences on the effects of migraines and the treatment options that could potentially mitigate complications for patients with cardiovascular concerns.
An agile pharma startup with a promising molecule in Phase III clinical trials desired to effectively build brand awareness and educate three distinct audiences on the effects of migraines and the treatment options that could potentially mitigate complications for patients with cardiovascular concerns.
Strategy
Branding & Identity
Web Design
Visual Design
Content Creation
Educating each audience based on their needs with respect to migraine diagnosis, treatment options, and research required tailored content curation with experts including neurologists, MDs, a biotech investment analyst, and CoLucid researchers.
Targeted content was distributed via the website, a third party analyst site, and conferences.
Educating each audience based on their needs with respect to migraine diagnosis, treatment options, and research required tailored content curation with experts including neurologists, MDs, a biotech investment analyst, and CoLucid researchers.
Targeted content was distributed via the website, a third party analyst site, and conferences.
Educating each audience based on their needs with respect to migraine diagnosis, treatment options, and research required tailored content curation with experts including neurologists, MDs, a biotech investment analyst, and CoLucid researchers.
Targeted content was distributed via the website, a third party analyst site, and conferences.
Educating each audience based on their needs with respect to migraine diagnosis, treatment options, and research required tailored content curation with experts including neurologists, MDs, a biotech investment analyst, and CoLucid researchers.
Targeted content was distributed via the website, a third party analyst site, and conferences.
Educating each audience based on their needs with respect to migraine diagnosis, treatment options, and research required tailored content curation with experts including neurologists, MDs, a biotech investment analyst, and CoLucid researchers.
Targeted content was distributed via the website, a third party analyst site, and conferences.
Let's talk
Let's talk
Let's talk
info@kingfishmedia.com
978 . 745 . 4140
info@kingfishmedia.com
978 . 745 . 4140
info@kingfishmedia.com
978 . 745 . 4140
Come aboard
Come aboard
Come aboard
Swing by
Swing by
Swing by
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston